Clinical implications of E-cadherin associated hereditary diffuse gastric cancer
- PMID: 15138199
- PMCID: PMC1774077
- DOI: 10.1136/gut.2003.022061
Clinical implications of E-cadherin associated hereditary diffuse gastric cancer
Abstract
Approximately 1-3% of gastric cancers arise as a result of inherited gastric cancer predisposition syndromes. These may be of the diffuse or intestinal type. Linkage analysis has recently implicated E-cadherin mutations in an estimated 25% of families with an autosomal dominant predisposition to diffuse type gastric cancers. This subset of gastric cancer has been termed hereditary diffuse gastric cancer (HDGC).
References
-
- Sokoloff B. Predisposition to cancer in the Bonaparte family. Am J Surg 1938;40:673–8.
-
- Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020–7. - PubMed
-
- La Vecchia C, Negri E, Franceschi S, et al. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70:50–5. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical